Michelle L. Basil
2018
In 2018, Michelle L. Basil earned a total compensation of $2.1M as Executive Vice President, General Counsel at Haemonetics.
Compensation breakdown
| Bonus | $150,000 |
|---|---|
| Non-Equity Incentive Plan | $411,321 |
| Option Awards | $249,999 |
| Salary | $425,818 |
| Stock Awards | $822,699 |
| Other | $22,371 |
| Total | $2,082,208 |
Basil received $822.7K in stock awards, accounting for 40% of the total pay in 2018.
Basil also received $150K in bonus, $411.3K in non-equity incentive plan, $250K in option awards, $425.8K in salary and $22.4K in other compensation.
Rankings
In 2018, Michelle L. Basil's compensation ranked 5,525th out of 14,244 executives tracked by ExecPay. In other words, Basil earned more than 61.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,525 out of 14,244 | 61st |
Division Manufacturing | 2,085 out of 5,765 | 64th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 261 out of 849 | 69th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 143 out of 547 | 74th |
Industry Surgical and Medical Instruments and Apparatus | 91 out of 348 | 74th |
Source: SEC filing on June 12, 2019.
Basil's colleagues
We found three more compensation records of executives who worked with Michelle L. Basil at Haemonetics in 2018.
News
Haemonetics CEO Christopher Simon's 2022 pay rises 1% to $8.7M
June 17, 2022
Haemonetics CEO Christopher Simon's 2021 pay slips 8% to $8.6M
June 17, 2021
Haemonetics CEO Christopher Simon's 2020 pay rises 10% to $9.4M
June 8, 2020
Haemonetics CEO Christopher Simon's 2019 pay rises 9% to $8.6M
June 12, 2019